Dermatome Device Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented by Product (Drum Dermatome Device, Knife Dermatome Device, Powered Dermatome Device), By Application (Plastic Surgery, Reconstructive Surgery, General Surgery, Chronic Burn Care Treatments, Others), By End User (Hospitals, Dermatology Clinics, Ambulatory Surgical Centers, Others), By Region and Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 235.77 Million
CAGR (2026-2031)	6.64%
Fastest Growing Segment	Chronic Burn Care Treatments
Largest Market	North America
Market Size (2031)	USD 346.74 Million

Market Overview

The Global Dermatome Device Market is projected to grow from USD 235.77 Million in 2025 to USD 346.74 Million by 2031 at a 6.64% CAGR. A dermatome device is a specialized surgical instrument designed to harvest thin, uniform slices of skin from a donor site for various skin grafting procedures. The market for these devices is significantly propelled by the increasing global incidence of burn injuries and severe skin trauma, alongside the growing volume of reconstructive and cosmetic surgeries that necessitate skin transplantation. Additionally, the rising prevalence of chronic skin conditions and an expanding geriatric population contribute to the demand for effective dermatological interventions.

However, a notable challenge impeding market growth is the substantial cost associated with the acquisition and maintenance of advanced dermatome systems, particularly in resource-constrained healthcare environments. According to the American Burn Association, in 2025, approximately 486,000 burn injuries received medical treatment annually in the U.S., highlighting the consistent need for these devices despite cost considerations.

Key Market Drivers

The increasing incidence of burn injuries significantly drives demand within the global dermatome device market. These devices are crucial for excising damaged skin and harvesting healthy grafts, a necessity in treating the severe tissue damage associated with burns. The long-term outlook highlights this persistent need, as a study published in Healthcare (Basel), August 2025, projected that severe burns could rise by 233.4% and mild burns by 142.5% globally by 2050, underscoring the ongoing requirement for effective skin grafting solutions. This sustained demand fuels innovation and adoption of dermatome technologies. Furthermore, the market's activity is evident through the financial performance of key industry players, with Integra LifeSciences Holdings Corporation reporting total revenues of $1,635.2 million for the full year 2025.

Another substantial factor propelling market growth is the growing volume of cosmetic and reconstructive surgeries. Dermatome devices are indispensable in procedures requiring precise skin removal for aesthetic enhancements, scar revisions, and reconstructive efforts following trauma or disease. According to the International Society of Aesthetic Plastic Surgery (ISAPS) Global Survey results, published June 2025, more than 17.4 million aesthetic surgical procedures were performed by plastic surgeons globally in 2024. This high volume of surgical interventions directly translates into a consistent need for dermatome devices, as skin grafting remains a fundamental technique across a wide spectrum of these specialized surgeries.

Download Free Sample Report

Key Market Challenges

The substantial cost associated with the acquisition and maintenance of advanced dermatome systems represents a significant challenge to the growth of the global dermatome device market. This financial burden directly limits the widespread adoption and integration of these specialized instruments, particularly within resource-constrained healthcare environments. High initial purchase prices, combined with ongoing expenses for calibration, specialized consumables, and routine servicing, impose considerable budgetary pressures on healthcare providers.

This challenge is especially pronounced for public hospitals, smaller surgical centers, and facilities in emerging economies, where capital expenditure is often prioritized for essential life-saving equipment. Consequently, the ability of these institutions to invest in or upgrade to newer dermatome technologies is significantly hampered. According to the American Hospital Association's 2026 Environmental Scan, in 2025, 94% of hospital administrators in the U.S. indicated plans to delay equipment upgrades due to financial strain. This pervasive financial caution within the healthcare sector directly translates to deferred purchasing decisions and slower market penetration for dermatome device manufacturers, inhibiting overall market expansion.

Key Market Trends

The integration of advanced automation and digital technologies represents a significant trend in the global dermatome device market, fundamentally reshaping surgical workflows and outcomes. This trend involves enhancing dermatome systems with features such as robotic assistance for improved precision, digital imaging for accurate graft sizing, and data integration for comprehensive patient record management. Such advancements aim to reduce human variability, optimize procedural efficiency, and ultimately lead to better patient recovery and reduced complications in skin grafting. According to Johnson & Johnson, in its "Q4 and Full-Year 2025 results" released in January 2026, MedTech worldwide operational sales grew 5.4%, driven partly by innovations in surgical products, reflecting the industry's broader movement towards digitally integrated surgical solutions.

Another impactful trend is the increasing adoption of disposable and sterilizable device solutions. This shift is driven by a heightened focus on infection control, reduction of cross-contamination risks, and streamlining surgical preparation and post-procedure cleanup. Disposable components, such as blades and sterile covers, minimize the need for complex and costly sterilization processes, contributing to operational efficiency within healthcare facilities. The emphasis on pre-sterilized and single-use items also helps meet stringent regulatory requirements and ensures consistent device performance. According to Medline Inc., in its "Fourth Quarter and Full Year 2025 Results" published in February 2026, full year net sales increased by 11.5%, with strong growth in its Medline Brand and Supply Chain Solutions segments, which include a wide array of medical-surgical products and single-use items.

Segmental Insights

The Global Dermatome Device Market is witnessing substantial growth, with the Chronic Burn Care Treatments segment emerging as a key driver. This segment's rapid expansion is primarily fueled by the escalating global incidence of severe and chronic burn injuries, which critically necessitate advanced surgical interventions for effective patient management and recovery. Dermatome devices are indispensable for facilitating precise skin grafting, a foundational procedure in reconstructive burn surgery that significantly enhances healing and functional outcomes. Furthermore, the continuous advancements in specialized burn care protocols and the expansion of dedicated burn treatment centers globally contribute to the heightened demand for these essential medical instruments. Organizations such as the World Health Organization highlight the significant burden of burn injuries worldwide, underscoring the vital role dermatomes play in addressing these complex healthcare challenges.

Regional Insights

North America leads the global dermatome device market due to its well-established healthcare infrastructure and substantial expenditure on surgical procedures. The region benefits from a high volume of reconstructive and elective cosmetic surgeries, coupled with a significant incidence of burn injuries and trauma cases that necessitate skin grafting. This robust demand is further supported by the presence of prominent medical device manufacturers and favorable reimbursement frameworks, which encourage the adoption of advanced dermatome technologies. Additionally, regulatory oversight from bodies like the U.S. Food and Drug Administration ensures high standards for device quality and safety, contributing to market confidence.

Recent Developments

• In January 2026, medical device startup SilkMed began advancing its proprietary sprayable silk-based technology for burn wound treatment. The company, which joined the Cambridge Innovation Center's Social Impact Cohort, is focused on developing an innovative wound-dressing technology derived from silk proteins. This sprayable solution is envisioned to revolutionize the burn wound industry by offering an alternative or complementary approach to existing treatments. This type of innovation in wound care for burns is relevant to the global dermatome device market as it seeks to enhance healing, potentially influencing the frequency or methods of traditional skin grafting.
• In January 2026, AVITA Medical, Inc., a therapeutic acute wound care company, presented data from multiple scientific abstracts at the Boswick Burn & Wound Symposium. The presentations highlighted the first surgeon-reported integrated use of AVITA Medical's three technologies: RECELL, PermeaDerm, and Cohealyx, in individual patient cases. These technologies aim to optimize wound healing and accelerate patient recovery for thermal burn and trauma wounds by utilizing a patient's own skin to create "Spray-On Skin" cells or support skin grafting readiness. Such integrated approaches in wound management offer advanced solutions that complement or provide alternatives to dermatome-assisted skin grafting procedures.
• In November 2025, Spectral AI, Inc., an artificial intelligence company, featured its DeepView System at leading U.S. burn conferences. The DeepView System is being developed as a predictive device to offer clinicians an objective and immediate assessment of a burn wound's healing potential before treatment. By providing fast and accurate treatment insights, this technology aims to improve patient outcomes and reduce healthcare costs in burn care. Such advancements in burn wound assessment directly impact the decision-making process for skin grafting procedures, which often utilize dermatome devices for harvesting skin.
• In May 2025, Inventia Life Science initiated world-first clinical trials for its novel 3D bioprinting device, LIGŌ, to treat skin wounds such as burn injuries. This groundbreaking medical device restores and regenerates damaged skin layers by delivering nano-sized droplets of bioink, created from the patient's own cells, directly to the wound site. The technology aims to eliminate the need for traditional skin harvesting for grafts, which typically involves dermatome devices, by providing a method for guided skin regeneration. This represents a significant advancement in skin replacement therapies, offering potential for improved patient outcomes and transforming approaches to wound repair.

Key Market Players

• Zimmer Biomet Holdings Inc.
• B.Braun Melsungen AG
• Integra Lifesciences Corporation
• Aesculap, Inc.
• Surtex Instruments Ltd.
• Humeca BV
• Nouvag AG
• Novo Surgical Inc.
• Aygun Surgical Instruments Co., Inc.
• Shaanxi Xingmao Industry Co., Ltd.

By Application	By End User	By Region
Plastic Surgery Reconstructive Surgery General Surgery Chronic Burn Care Treatments Others	Hospitals Dermatology Clinics Ambulatory Surgical Centers Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Dermatome Device Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Dermatome Device Market, By Application:

• Plastic Surgery
• Reconstructive Surgery
• General Surgery
• Chronic Burn Care Treatments
• Others

• Dermatome Device Market, By End User:

• Hospitals
• Dermatology Clinics
• Ambulatory Surgical Centers
• Others

• Dermatome Device Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE